Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-24-002575

EVP & Group Pres, Cardiology gave up 5,692 shares (to pay taxes)

  • EVP & Group Pres, Cardiology acquired 11,833 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 2024-02-16 Option exercise +3,960 190,686 D
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 2024-02-16 Shares withheld for taxes −1,806 $65.82 $118,871 188,880 D
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 2024-02-17 Option exercise +4,167 193,047 D
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 2024-02-17 Shares withheld for taxes −2,057 $65.82 $135,392 190,990 D
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 2024-02-18 Option exercise +3,706 194,696 D
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 2024-02-18 Shares withheld for taxes −1,829 $65.82 $120,385 192,867 D
Derivatives
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 2024-02-16 Option exercise · Restricted Stock Units −3,960 7,920 D
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 2024-02-17 Option exercise · Restricted Stock Units −4,167 4,167 D
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 2024-02-18 Option exercise · Deferred Stock Units −3,706 0 D
Loading xslF345X05/doc4.xml…